Robert G. Uzzo MD, MBA, FACS
Deputy Chief Clinical Officer and Director, Surgical Services, Fox Chase Cancer Center/Jeanes Hospital; Chairman, Department of Surgical Oncology, Fox Chase Cancer Center; G. Willing “Wing” Pepper Professor of Urological Oncology, Fox Chase Cancer Center/Temple University; Chair, Fox Chase/Einstein Urologic Institute, Philadelphia, PennsylvaniaDr. Uzzo graduated summa cum laude from Union College and attended Cornell University Medical College. He completed general surgical training followed by urologic surgical training at New York Hospital - Cornell Medical Center and Memorial Sloan-Kettering Cancer Center. He was an American Foundation for Urological Diseases Scholar in Urological Oncology and completed both Oncological and Renal Transplantation Fellowships at the Cleveland Clinic.
Dr. Uzzo is currently the Deputy Chief Clinical Officer; Director of Surgical Services, Fox Chase Cancer Center/Jeanes Hospital; Chairman of the Department of Surgical Oncology, Fox Chase Cancer Center; and the G. Willing “Wing” Pepper Professor of Urological Oncology at Fox Chase Cancer Center/Temple University. He is also the Chair of the Fox Chase/Einstein Urologic Institute. He maintains an active, funded laboratory investigating kidney and prostate cancer. His clinical interests include minimally invasive urological oncology and renal malignancies. He has authored over 300 peer-reviewed articles in urologic oncology.
Recent Contributions to PracticeUpdate:
- Growth Kinetics of Small Renal Masses on Active Surveillance
- Natural History, Predictors, and Management of Ureteroenteric Strictures After Robot-Assisted Radical Cystectomy
- Surgical Histopathology for Suspected Oncocytoma on Renal Mass Biopsy
- Percutaneous Renal Biopsies for Small Renal Masses: Complex Tumors on Nephrometry Should Be the First Targets
- Atezolizumab Adjuvant Study: Urologist Perspective
- Renal Mass Biopsy: Always, Sometimes, or Never?
- Nephron-Sparing Surgery—Outcomes From a National Partial Nephrectomy Audit
- Systematic Review and Meta-Analysis of Diagnostic Accuracy of Percutaneous Renal Tumor Biopsy
- Surgery for High and Very High Risk Prostate Cancer Is Feasible, Safe, and Effective
- Risk Factors for Recurrence After Surgery in Non-Metastatic RCC With Thrombus